Eye drops that restore vision: topical gene therapy reveals surprising results

You eyes, true windows to the world, are sensitive organs that deserve attention and adequate care. The constant use of electronic devices, exposure to influence and various environmental factors can contribute to the incidence of eye discomfort and vision problems.

In this scenario, eye drops emerge as a fundamental ally for ophthalmological care and to maintain eye health.

Eye drops are a liquid ophthalmic solution used to lubricate, clean, soothe and treat different eye conditions. It can be applied directly to the eye, whether to reduce irritation, alleviate allergy symptoms, correct dry eyes or, in some cases, treat complications and inflammation.

Seeing again

Photo: Istoé/Reproduction

Recently, groundbreaking news brought hope and excitement to those facing vision challenges. It involves the development of a eye drops innovative which is currently in an advanced testing phase.

The success story of this eye drop came to light through a moving case involving a young Cuban boy of just 14 years old, who suffered from serious vision problems and was practically blind.

Surprisingly, after using the experimental eye drops, the teenager experienced a notable improvement and, impressively, partially recovered his vision. The boy has so-called dystrophic epidermolysis bullosa (DBE), a illness rare and serious that affects the skin and mucous membranes.

It belongs to a group of genetic diseases known as epidermolysis bullosa, characterized by the formation of blisters and lesions on the skin and mucous membranes in response to minimal or unexplained trauma. This condition is hereditary and is caused by genetics that determine proteins for the integrity of the skin.

In the dystrophic form of epidermolysis bullosa, there is a failure in the production of type VII collagen protein, essential for maintaining adhesion between the layers of the skin. As a result, the skin becomes extremely fragile, prone to forming blisters and wounds easily, even when faced with small shocks or pressure.

As we can imagine, this disease does not leave the person’s eyes immune, which means that Antonio, due to the disease, had his eyes seriously damaged, leading to blindness.

Topical gene therapy

An innovative medical approach that is gaining increasing recognition due to its remarkable results in treating genetic diseases is Topical Gene Therapy.

This type of therapy consists of the direct delivery of genetic material in specific cells of the body, and is commonly applied to localized areas through topical formulations, such as creams, gels or eye drops.

Initially, Topical Gene Therapy was applied to Antonio’s skin, which resulted in notable improvements in reducing the incidence of blisters. The results were lasting and promising, providing considerable relief for the young patient.

However, even with the improvement in his skin, his eyes remained affected by the condition and Antonio was still unable to see. It was then that the dedicated Dr. Alfonso Sabater, the doctor responsible for Antonio’s treatment, decided to explore a new approach.

Inspired by the successes achieved with Topical Gene Therapy on the patient’s skin, he decided to apply the same strategy to Antonio’s eyes, using a special formulation in the form of eye drops.

The results of this innovative attempt were impressive. Antonio began to show progressive improvement in his vision and, over time, his ability to see was significantly restored.

The eye drops containing the correct genetic material proved effective in correcting the anomalies present in Antonio’s eyes, bringing hope and a new perspective to the young patient and his family.

Without a doubt, the promising results observed in the application of Topical Gene Therapy in cases like Antonio’s are very encouraging and suggest great potential for to benefit a significant number of people in the future.